Search

Search Constraints

You searched for: Author/Creator Fujita, Shiro

Search Results

1. 420.2: Early Experience of Solid Organs Transplantation From COVID-19 Positive Donors in a Single Institute. (13th September 2022)

2. 420.2: Early Experience of Solid Organs Transplantation From COVID-19 Positive Donors in a Single Institute. (13th September 2022)

3. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109). Issue 2 (February 2015)

4. A phase 2 study of bevacizumab in combination with carboplatin and paclitaxel in patients with non-squamous non-small-cell lung cancer harboring mutations of epidermal growth factor receptor (EGFR) after failing first-line EGFR-tyrosine kinase inhibitors (HANSHIN Oncology Group 0109). Issue 2 (February 2015)

6. ALBI GRADE AT 30 DAYS AFTER TRANSARTERIAL RADIOEMBOLIZATION HAVE POOR PROGNOSIS AFTER LIVER TRANSPLANTATION. Issue 3 (September 2020)

7. Efficacy and safety of nivolumab in Japanese patients with advanced or recurrent squamous non‐small cell lung cancer. Issue 5 (26th April 2017)

8. Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non‐small cell lung cancer. Issue 12 (31st October 2020)

9. EGFR Mutation Impact on Definitive Concurrent Chemoradiation Therapy for Inoperable Stage III Adenocarcinoma. Issue 12 (December 2015)